Table 1. Clinical characteristic of the study participants.
| Characteristic | Baseline | 12 months post-surgery | P-value |
|---|---|---|---|
| Body weight (kg) | 152 ± 36.3 | 110 ± 21.1 | 5.6E-05 |
| BMI (kg/m2) | 53.1 ± 10.1 | 38.6 ± 6.69 | 3.2E-06 |
| Fasting plasma glucose (FPG) (mmol/l) | 6.87 ± 1.81 | 5.16 ± 0.71 | 4.0E-04 |
| Fasting plasma insulin (FPI) (pmol/l) | 191 ± 145 | 66.5 ± 46.1 | 9.6E-04 |
| HbA1c (%) | 6.23 ± 0.93 | 5.31 ± 0.50 | 3.6E-04 |
| Triacylglycerol (TG) (mmol/l) | 1.78 ± 0.56 | 1.10 ± 0.36 | 4.2E-05 |
| Free fatty acids (FFA) (mmol/l) | 0.93 ± 0.25 | 0.37 ± 0.20 | 5.1E-10 |
| Total cholesterol (mmol/l) | 4.97 ± 0.93 | 4.73 ± 0.74 | 0.34 |
| LDL-cholesterol (mmol/l) | 3.14 ± 0.67 | 2.97 ± 0.84 | 0.51 |
| HDL-cholesterol (mmol/l) | 1.04 ± 0.31 | 1.39 ± 0.28 | 4.8E-04 |
| C-reactive protein (CrP) (mg/l) | 6.11 ± 3.26 | 2.26 ± 1.39 | 2.9E-05 |
| Alanine aminotransferase (μkat/l) | 0.83 ± 0.41 | 0.48 ± 0.25 | 1.8E-03 |
| Aspartate transaminase (μkat/l) | 0.66 ± 0.33 | 0.39 ± 0.16 | 2.3E-03 |
| γ-Glutamyl transferase (μkat/l) | 0.82 ± 0.63 | 0.41 ± 0.18 | 8.5E-03 |
| Leptin (ng/ml) | 57.9 ± 16.9 | 33.0 ± 10.6 | 1.8E-06 |
| Adiponectin (μg/ml) | 4.88 ± 3.04 | 10.3 ± 2.25 | 9.1E-08 |
Data are shown as means ± SD. P-value indicates significance-level of difference before and after weight loss for the 22 individuals undergoing bariatric surgery.